US

Verato raises $10 mln

Blue Heron Capital said Jan. 9 that it participated in Verato’s $10 million Series C round. Existing investors, Bessemer Venture Partners and Columbia Capital, also took part. Verato, of McLean, Virginia, provides cloud-based patient matching and master patient index (MPI) solutions.

Insight Venture Partners invests $60 mln in TaxJar

TaxJar said Jan. 9 that it raised $60 million in funding from Insight Venture Partners. TaxJar, of Boston, is a sales tax automation company.

Cynerio raises $7 mln

Cynerio said Jan. 9 that it raised $7 million in funding. Investors including Accelmed, RDC and MTIP. Cynerio provides medical device and Internet of Medical Things (IoMT) security solutions.

GAN Integrity raises $15 mln

GAN Integrity said Jan. 9 that it raised $15 million in Series B financing led by Aquiline Technology Growth. Existing investors, including Edison Partners, participated in the round. GAN Integrity, of New York, develops compliance management software.

EQT Ventures adds partners to its London team

EQT Ventures announced this week that Johan Svanström and Lyle Fong have joined London team as partners. The firm, launched nearly three years ago, now has 30 team members worldwide in six cities, London, San Francisco, Berlin, Paris, Stockholm and Amsterdam. Svanström was previously president of Hotels.com and Fong is a serial entrepreneur, having founded enterprise software and gaming companies, including Lithium.

Optum Ventures backs AbleTo

AbleTo, a provider of virtual behavioral health care, has secured an undisclosed amount of funding. The investor was Optum Ventures.

Keros Therapeutics nets $23 mln Series B

Lexington, Massachusetts-based Keros Therapeutics, which is focused on developing treatments for neuromuscular diseases, has raised $23 million in Series B financing. The investors included Pontifax, Arkin Bio Ventures, Partners Innovation Fund, Medison Pharma and Global Health Sciences Fund.

Stelexis Therapeutics procures $43 mln Series A

New York-based Stelexis Therapeutics, a cancer therapeutics firm, has secured $43 million in Series A financing. Stelexis is backed by Deerfield.

Apollomics racks up $100 mln Series B

Apollomics Inc, a biopharmaceutical company focused on oncology combination therapies, has raised $100 million in Series B financing. CMB International led the round with participation from other investors that included OrbiMed Asia.

Spring Lake leads Series A round for Forefront Telecare

Novato, California-based Forefront Telecare Inc, a provider of behavioral telehealth services to seniors in rural facilities in the U.S., has raised an undisclosed amount of Series A funding. Spring Lake Equity Partners led the round.